Wall Street analysts expect Synopsys, Inc. (NASDAQ:SNPS) to announce $826.21 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for Synopsys’ earnings. The lowest sales estimate is $819.60 million and the highest is $830.00 million. Synopsys posted sales of $776.84 million in the same quarter last year, which would indicate a positive year over year growth rate of 6.4%. The business is expected to report its next earnings report on Wednesday, May 22nd.

According to Zacks, analysts expect that Synopsys will report full year sales of $3.33 billion for the current financial year, with estimates ranging from $3.32 billion to $3.34 billion. For the next financial year, analysts forecast that the firm will report sales of $3.54 billion, with estimates ranging from $3.50 billion to $3.61 billion. Zacks’ sales calculations are a mean average based on a survey of research analysts that follow Synopsys.

Synopsys (NASDAQ:SNPS) last announced its earnings results on Wednesday, February 20th. The semiconductor company reported $1.08 EPS for the quarter, topping the consensus estimate of $0.57 by $0.51. The business had revenue of $820.40 million for the quarter, compared to the consensus estimate of $796.30 million. Synopsys had a return on equity of 17.23% and a net margin of 18.59%. Synopsys’s revenue was up 6.6% compared to the same quarter last year. During the same period in the previous year, the business earned $1.10 EPS.

SNPS has been the topic of several recent analyst reports. DA Davidson boosted their target price on Synopsys to $125.00 and gave the stock a “positive” rating in a report on Thursday, February 21st. BidaskClub raised Synopsys from a “hold” rating to a “buy” rating in a report on Saturday, February 9th. Berenberg Bank initiated coverage on Synopsys in a report on Tuesday, November 20th. They set a “buy” rating and a $119.00 price objective on the stock. Needham & Company LLC upped their price objective on Synopsys from $105.00 to $115.00 and gave the stock a “buy” rating in a report on Thursday, December 6th. Finally, Benchmark raised Synopsys from a “hold” rating to a “buy” rating and set a $110.00 price objective on the stock in a report on Thursday, December 6th. One analyst has rated the stock with a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $112.63.

In other Synopsys news, VP Sudhindra Kankanwadi sold 2,085 shares of the company’s stock in a transaction on Tuesday, February 26th. The shares were sold at an average price of $102.71, for a total transaction of $214,150.35. Following the completion of the sale, the vice president now owns 10,387 shares in the company, valued at approximately $1,066,848.77. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, General Counsel John F. Runkel, Jr. sold 10,000 shares of the company’s stock in a transaction on Friday, February 22nd. The shares were sold at an average price of $101.71, for a total transaction of $1,017,100.00. Following the sale, the general counsel now owns 21,071 shares of the company’s stock, valued at approximately $2,143,131.41. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 127,190 shares of company stock worth $13,005,568. Company insiders own 1.84% of the company’s stock.

Institutional investors have recently modified their holdings of the business. Executive Wealth Management LLC bought a new stake in shares of Synopsys in the 4th quarter valued at $29,000. Trust Co. of Vermont bought a new stake in shares of Synopsys in the 4th quarter valued at $29,000. Legacy Financial Advisors Inc. increased its position in shares of Synopsys by 4,987.5% in the 4th quarter. Legacy Financial Advisors Inc. now owns 407 shares of the semiconductor company’s stock valued at $34,000 after buying an additional 399 shares in the last quarter. Riverview Trust Co bought a new stake in shares of Synopsys in the 4th quarter valued at $35,000. Finally, Lindbrook Capital LLC bought a new stake in shares of Synopsys in the 4th quarter valued at $61,000. Institutional investors own 88.81% of the company’s stock.

Shares of SNPS opened at $109.17 on Thursday. The company has a market capitalization of $16.34 billion, a PE ratio of 38.71, a price-to-earnings-growth ratio of 3.42 and a beta of 1.29. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.82 and a current ratio of 0.89. Synopsys has a one year low of $79.14 and a one year high of $110.15.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits (ICs). It offers Fusion Design Platform, a digital design implementation solution; Verification Continuum Platform, which provides virtual prototyping, static and formal verification, simulation, emulation, field-programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Featured Article: How Do Tariffs Affect Trade Balances?

Get a free copy of the Zacks research report on Synopsys (SNPS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.